Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions
International Journal of Rheumatic Diseases · 2026-07 · 29 (7)
DOI: 10.1111/1756-185x.70759 ↗Kurz gefasst
Editorial in der Zeitschrift International Journal of Rheumatic Diseases, online erschienen am 05.07.2026. Verfasst von Tang-Kai Cheng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan. Die Arbeit nennt 9 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
- Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
- Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.
ORCID-Profile: Tang-Kai Cheng, James Cheng-Chung Wei
Zitieren
APA
Cheng, T. K., & Wei, J. C. (2026). Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions. International Journal of Rheumatic Diseases, 29(7). https://doi.org/10.1111/1756-185x.70759
Vancouver
Cheng TK, Wei JC. Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions. International Journal of Rheumatic Diseases. 2026;29(7). doi:10.1111/1756-185x.70759
BibTeX
@article{Cheng2026,
author = {Cheng, Tang-Kai and Wei, James Cheng-Chung},
title = {Bridging the Gap in Hydroxychloroquine Monitoring for SLE : Evidence, Limitations, and Future Directions},
journal = {International Journal of Rheumatic Diseases},
year = {2026},
volume = {29},
number = {7},
doi = {10.1111/1756-185x.70759}
}
EUVIMED